Action INBS INTELLIGENT BIO SOLUTIONS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Intelligent Bio Solutions Inc.

Actions

INBS

US36151G6008

Cours en clôture Nasdaq
Autres places de cotation
 00:00:00 27/06/2024 		Varia. 5j. Varia. 1 janv.
1,87 USD +5,65% Graphique intraday de Intelligent Bio Solutions Inc. +2,75% -53,88%
18/06 Intelligent Bio Solutions Inc. commence le dosage et l'échantillonnage des sujets dans le cadre de l'étude pharmacocinétique (PK) 510(k) de la FDA pour sa technologie intelligente de dépistage des drogues par empreintes digitales. CI
12/06 Intelligent Bio Solutions ajoute un important fournisseur européen de solutions de transport et d'infrastructure au nombre croissant de ses clients qui adoptent la technologie de dépistage de drogues par empreintes digitales. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Kaival Brands Innovations Group (NASDAQ: KAVL) Secures $6M in Public Offering, Stock Surges Watch VTAK, OCGN, DYAI, INBS
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
INTELLIGENT BIO SOLUTIONS BEGINS SUBJECT DOSING AND SAMPLING FOR FDA 510(K) PHARMACOKINETIC STUDY FOR ITS INTELLIGENT FINGERPRINTING DRUG SCREENING TECHNOLOGY
Catheter Precision (NYSE American: VTAK) Announces New LockeT Purchase Order and Expands Sales Team Amid Surge in Trading Volume
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Intelligent Bio Solutions Inc. Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Intelligent Bio Solutions Inc. Announces Board Changes
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
Nasdaq Stocks Soaring to the Top with Strategic Splits: NVDA, INBS, JAGX, SINT, GWAV
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
Intelligent Bio Solutions Starts Subject Screening for Drug Testing System Study
Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
Intelligent Bio Solutions Inc. Completes Recruitment and Begins Subject Screening for FDA 510(K) Pharmacokinetic Study
Spotlighting Unexplored Stocks in Focus: NKGN, INBS, BTBT, PRSO, MGOL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action INBS
  4. Actualités Intelligent Bio Solutions Inc.
  5. Autres langues